New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]
Update: 2024-03-27
Description
MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
Comments
In Channel